Analysis

  • Amendments Set to Clear Ambiguity

    The US government is imposing transparency rules on the relationship between physicians and pharmaceutical companies. But are the major players ready to handle this? Penny Jones reports.

  • Tracking the Drug Trail

    Counterfeiting and fraud are significantly large risk factors when it comes to the safety of pharmaceutical products. Huw Kidwell follows the latest in developments in the pharmaceutical supply chain that...

Go Top